Investors & Media

OTCQB: INTI
PRICE:
Stock Info
Company Overview

Inhibitor Therapeutics, Inc. (OTCQB:INTI) is a pharmaceutical development company that discovers, develops and plans to commercialize innovative therapeutics to inhibit the progression of cancerous and non-cancerous proliferation disorders.  On August 20, 2019, we formally changed our corporate name from “HedgePath Pharmaceuticals, Inc.” to “Inhibitor Therapeutics, Inc.” and our stock symbol from “HPPI” to “INTI.”  On this page you will find important investor information.

Recent News
Oct 31, 2019

INHIBITOR Therapeutics, Inc. (OTCQB: INTI), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics to inhibit the progression of...

Aug 19, 2019

HedgePath Pharmaceuticals, Inc. (OTCQB:HPPI), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics to inhibit the progression of...

Events & Presentations
Get Important News and Updates by Email
* Required Fields